Better lung disease screening for people with addictions
Researchers from King’s have helped to develop a COPD (chronic obstructive pulmonary disease) ‘checklist’, to enable addictions...
04 August 2017
Over the past two decades, researchers from King’s College London have significantly changed public policy on naloxone, a fast-acting antidote which revives someone suspected of heroin overdose.
Over the past two decades, researchers from King’s have significantly changed public policy on naloxone, a fast-acting antidote which revives someone suspected of heroin overdose.
Naloxone is a ‘take home’ solution which can be administered by friends and family to provide crucial extra time to seek further medical treatment.
In this new video Professor Sir John Strang, Head of the Addictions Department at King’s, reflects on 20 years of research and looks ahead to future developments for the life-saving antidote.
Professor Sir John Strang’s research was nominated for last year’s PLuS Alliance Prize, announced at the Times Higher Education World Academic Summit.
The PLuS Alliance Prize awards $50,000 USD to globally-significant innovation in research and education which makes a direct and positive impact on communities. Find out more about the PLuS Alliance on its website.
Find out more by visiting our Making a Difference pages.
Related Spotlight story